# Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma

> **NCT02417194** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 238 (estimated)

## Conditions studied

- Carcinoma, Renal Cell
- Pathology
- Treatment Outcome
- Hemoglobin A1c Protein, Human

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02417194
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2015-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417194, "Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02417194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*